Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 28:13:1797-1807.
doi: 10.2147/OTT.S239336. eCollection 2020.

A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer

Tuo Ruan  1 , Weizhen Liu  1 , Kaixiong Tao  1 , Chuanqing Wu  1
Affiliations
Review

A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer

Tuo Ruan et al. Onco Targets Ther. .

Abstract

Gastric cancer is one of the most common malignant tumors, and it is also one of the leading causes of cancer death worldwide. Because of its insidious symptoms and lack of early dictation screening, many cases of gastric cancer are at late stages which make it more complicated to cure. For these advanced-stage gastric cancers, combination therapy of surgery, chemotherapy, radiotherapy and target therapy would bring more benefit to the patients. However, the drug-resistance to the chemotherapy restricts its effect and might lead to treatment failure. In this review article, we discuss the mechanisms which have been found in recent years of drug resistance in gastric cancer. And we also want to find new approaches to counteract chemotherapy resistance and bring more benefits to the patients.

Keywords: chemotherapy; gastric cancer; resistance.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
The summary of mechanisms of drug resistance in gastric cancer.
See this image and copyright information in PMC

References

    1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262 - DOI - PubMed
    1. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338 - DOI - PubMed
    1. Huang H, Yang X-J, Gao R. Research Advances in the Mechanisms of Gastric Cancer Multidrug Resistance. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016;38(6):739–745. doi:10.3881/j.issn.1000-503X.2016.06.020 - DOI - PubMed
    1. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20. doi:10.1056/NEJMoa055531 - DOI - PubMed
    1. Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol. 2009;71(2):127–164. doi:10.1016/j.critrevonc.2009.01.004 - DOI - PubMed